AzTrials
AzTrials

GamblingICBTNCT06171516

Internet-based Cognitive Behavioral Therapy for Individuals With Gambling Disorder in Indonesia

A study testing iCBT in people with Gambling, run by Universitas Indonesia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Gambling disorder (GD) has become a wide concern in Indonesia, as many negative consequences aroused from this psychiatric condition. Prompt treatment with appropriate method of delivery is required to achieve optimal outcome in GD patients. Read more about this study

Who is it for?
Ages 18 to 59 years
Conditions the study is for
Gambling
What is being tested?
iCBT
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
No sites listed yet
Study dates
Aug 2024to Jan 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 59 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • be aged 18-59 years old;
  • be screened as probable pathological gambler based on South Oaks Gambling Screen (SOGS);
  • have access to electronic devices (ie, smartphone, mobile tablet, personal computer) with internet connection;
  • be proficient in Indonesian language;
  • have agreed to take part in the study by filling out the informed consent form.

Who cannot join

  • have severe mental disorders or intellectual disabilities;
  • have extreme agitation that hinder instrument fill out and adequate cognitive behavior therapy participation.

About this study

Official title: Internet-based Cognitive Behavioral Therapy for Individuals With Gambling Disorder in Indonesia: a Pilot and Feasibility Study

Gambling disorder (GD) has become a wide concern in Indonesia, as many negative consequences aroused from this psychiatric condition. Prompt treatment with appropriate method of delivery is required to achieve optimal outcome in GD patients. This study aims to determine the effectiveness and feasibility of internet-based cognitive behavioral therapy (iCBT) in treating GD.

This non-randomised pilot and feasibility study will recruit 20 people with GD. All participants will receive the iCBT intervention through self-learning videos and guided weekly group sessions. The effectiveness of the intervention will be assessed at baseline (week 0), post-treatment completion (week 10), and 6 weeks post-treatment (week 16).

Expanded access of the iCBT module will not be available until after the study completion.

Conditions
Gambling
Being tested
iCBT
Medical subject headings
Gambling

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • iCBTBehavioural

    All participants will undergo 10 guided therapy sessions (once-weekly) with each session lasting 20 minutes. The therapy module will be given as an online self-learning source via videos in a website specifically developed for this training. The videos will divide the module content into several parts with each video lasting about 10 minutes.

Study groups in NCT06171516
Study groupRoleWhat they receive
Internet-based Cognitive Behavioral TherapyExperimental10 guided therapy sessions (once-weekly) with each session lasting 20 minutes.
Receives: Behavioral: iCBT

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gambling symptom severity

    a decrease in Gambling Symptom Assessment Scale (G-SAS) score

    Measured: G-SAS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

  2. Problem gambling severity

    a decrease in Problem Gambling Severity Index score

    Measured: PGSI will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

  3. Gambling urges

    a decrease in Gambling Urge Scale (GUS) score

    Measured: GUS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

  4. Gambling-related cognitive distortions

    a decrease in Gambling Related Cognitions Scale (GRCS) score

    Measured: GRCS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

Secondary outcomes (2)
  1. Nonspecific psychological distress

    a decrease in Self Rating Questionnaire-20 (SRQ-20) score

    Measured: SRQ-20 will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

  2. Subjective quality of life

    an increase in World Health Organization Quality-of-Life Scale (WHOQOL-BREF) score

    Measured: WHOQOL-BREF will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Dec 2023
  2. Study startAug 2024 (estimated)
  3. Primary completionNov 2024 (estimated)
  4. Study completionJan 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
20 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06171516
Sponsor's protocol ID
KET-992-2023
Acronym
ICBT
Status last verified
Jul 2024
First submitted
6 Dec 2023
Last updated
11 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing iCBT in people with Gambling, run by Universitas Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 11 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Gambling symptom severity (time frame: G-SAS will be assessed at baseline (week 0), post-treatment (week 6), and follow-up (week 16)). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in